Loading
CuraFi is a healthcare technology company based in San Francisco, California, founded in 2022. It specializes in an AI-powered drug cost management and clinical decision support platform that aligns clinical choices with financial goals for risk-bearing organizations. The company aims to address the financial challenges associated with high-cost therapeutics by integrating value-based care with advanced AI technology. CuraFi's core offering includes an all-in-one software solution that embeds AI directly into Electronic Medical Records (EMR). This technology assists healthcare providers by surfacing accurate coding, in-network referrals, and cost-effective therapy options. The platform also predicts drug prices, benchmarks utilization, and identifies patients at risk for suboptimal prescribing. Additionally, CuraFi provides automated administrative solutions for infusion management and care coordination, helping organizations streamline processes and deliver personalized care pathways. The company primarily serves B2B stakeholders in the healthcare industry, including insurers, physician groups, biopharma companies, infusion providers, and healthcare centers.